GRAM NEGATIVES STUDY
Condition(s) studied
Investigational drug(s) / intervention(s)
Standard of care therapy: This is an observational study. Patients receive standard of care therapy as part of routine clinical practice according to the physician's discretion. No experimental intervention is assigned by the protocol.
Study summary
This is a prospective, observational, multicenter study whose main objective is to develop a predictive model of mortality in critically ill patients colonized by multidrug-resistant Gram-negative bacteria (MDR-GNB).
Secondary objectives include: determining the characteristics of patients colonized by MRGB who require admission or acquire colonization during their stay in an intensive care unit (ICU); studying the infectious complications they develop, their etiology, clinical impact, and prognosis.
Eligibility
Primary outcome measure(s)
- In-hospital all-cause mortality — From ICU admission until hospital discharge or death, assessed up to hospital discharge.
Development and validation of a predictive model for in-hospital mortality in patients colonized by multidrug-resistant Gram-negative bacteria admitted to intensive care units.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hospital Universitario La Paz | Madrid | Madrid | Recruiting |
More Fundacion SEIMC-GESIDA trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07749508 on ClinicalTrials.gov ↗ ← All trials in Spain